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BACKGROUND:  Merkel  cell  carcinoma  (MCC)  is an  aggressive  cutaneous  neuroendocrine  carcinoma  that
affects elderly  patients  and  typically  arises  in  sun-exposed  skin.  The  disease  is  very  rare  and  only  few
cases  present  with  no  apparent  skin  lesion.  In the  retroperitoneum  there  are only  two  cases  reported  in
the  literature.
CASE  PRESENTATION:  We  report  a case  of a  54-year-old  Mexican  male  with  MCC,  which  presented  as  a
large  retroperitoneal  mass.  Pathological  and  immunohistochemical  analysis  of the  transabdominal  CT-
guided  biopsy  specimen  revealed  a MCC.  The  patient  underwent  preoperative  chemotherapy  followed
by  a laparotomy  and  the  mass  was  successfully  excised.
DISCUSSION:  There  are  two  possible  explanations  for what  occurred  in  our patient.  The  most  plausible
theory  is  the  retroperitoneal  mass  could  be a massively  enlarged  lymph  node  where  precursor  cells
became  neoplastic.  This  would  be  consistent  with  a  presumptive  diagnosis  of  primary  nodal  disease.
Moreover,  metastasis  to  the  retroperitoneal  lymph  nodes  has  been  reported  as  relatively  common  when
compared  to  other  sites  such  as liver,  bone,  brain  and  skin.  The  less  probable  theory  is  the  non-described
“regression”  phenomena  of  a cutaneous  MCC,  but we  are  not  found  a primary  skin  lesion.
CONCLUSION:  Preoperative  chemotherapy  and  excision  of  the  primary  tumor  is the  surgical  treatment  of
choice  for  retroperitoneal  MCC.  We  propose  that further  studies  are  needed  to  elucidate  the  true  efﬁcacy
of  chemotherapy  in conventional  and  unconventional  patients  with  MCC.
©  2015  The  Authors.  Published  by Elsevier  Ltd.  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
This report examines the unusual case of a patient with Merkel
ell carcinoma (MCC) of retroperitoneal origin without evidence of
isease in another site in the body. In the current literature, there
re a very few cases worldwide of MCC  cases originated out of the
kin.
MCC  is a rare skin tumor that was ﬁrst described by Toker
n 1972. The cells arise from the amine precursor uptake and
ecarboxylation cell system, and recent studies suggest that they
evelop from an epidermal cell lineage. With an incidence of
.18–0.41/100,000, they represent a fraction of skin cell tumors,
nd UV light is a known risk factor [1]. Primary extracutaneous
ases are very rare, with only a few cases reported in the literature;
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most present in the lymph nodes without a cutaneous tumor [2].
To the best of our knowledge and after a broad review, through
July 2015 we identiﬁed only three cases of primary retroperitoneal
MCC  in the literature [3–5]. Furthermore, whereas MCC  shows a
propensity for local spread and metastasis to regional lymph nodes,
and although distant metastasis has been reported in multiple sites
including intra-abdominal, thoracic, and the central nervous sys-
tem [6,7], retroperitoneal or pancreatic metastasis is very rare. An
extensive literature search identiﬁed only 10 cases of MCC  metas-
tasizing to the retroperitoneum [8–17]. We present the case of a
primary retroperitoneal MCC  and review the literature, concentrat-
ing in particular on the clinical presentation of this rare disease.
2. Case reportA 54 year old man, without signiﬁcant personal or familial
history of cancer, presented in our institution with vague and dif-
fuse abdominal pain in September of 2011. Physical examination
showed a palpable mass in the right ﬂank and right iliac fosse
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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F  mass. (b) The neoplasm extends through the left primitive iliac vein until the bifurcation,
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(ig. 1. (a) Computer tomography scan shows a lobulated paraaortic retroperitoneal
ncasing the external left iliac vein. (c) The neoplasm compresses pelvic structures
hat was mobile and of irregular contour. The computer tomog-
aphy (CT) showed a retroperitoneal mass of 11 × 9 × 7 cm with
xtrinsecal compression of the sigmoid colon and urinary bladder
Fig. 1a). In addition, there were multiple para-aortic and left iliac
ymphadenopathies measuring up to 50 mm of diameter (Fig. 1b
nd c). This adenopathies caused functional exclusion of the left
idney. In October 2011 a CT-guided biopsy was taken from the
umor that conﬁrmed the diagnosis.
A PET-CT scan was performed with 68Ga-DOTATOC in
ovember 2011 and showed bilateral cervical lymphadenopathies
ith SUVmax of 7.4, and a right pharyngeal nodule of 1.7 cm with
UVmax of 5.3. The patient was treated with systemic chemother-
py with six cycles of Carboplatin (570 mg)  and Etoposid (190 g)
rom November 2011 to March 2012, and disease progression was
ocumented with a PET-CT scan in April 2012 (i.e., increased of size
f the retroperitoneal mass).
A  surgery was performed in June 2012 found a 12 × 8 cm
etroperitoneal tumor that was hardly attached to the left external
liac vein with extension to cava vein. The duration of the surgery
as 210 min  and the postoperative stay was of three days, with-
ut complications. The ﬁnal diagnosis of the surgical specimen was
CC. The patient was taken to adjuvant radiotherapy with 50.4 Gy
rom September 2012 to October 2012. During a follow-up visit
n May  2013, a PET-CT scan showed disease progression with a
ight lung nodule of 4 mm and an 18 mm hepatic nodule. Pallia-
ive chemotherapy was offered to the patient; however, the patient
eclined treatment and was attended for the last time in September
013, with stable disease. The patient was lost in the follow-up.
.1. Pathologic ﬁndings
Pathologically, the mass was a white grayish retroperitoneal
ass 12 cm in diameter, histologically composed of small to
edium round cells, and with a high nuclear-to-cytoplasmic ratio
ith an area of vague trabeculae that was highly suggestive of MCC
Fig. 2). Immunohistochemistry conﬁrmed this ﬁnding, as the massFig. 2. Microscopic details of the neoplasm showing the characteristic “merkeloid”
open dusty chromatin with eccentric nucleoli and a solid and trabecular growth
pattern. There are multiple abnormal mitotic ﬁgures.
was positive for CD56, synaptophysin, CKAE/AE3, and a character-
istic paranuclear cytokeratin (CK) 20 staining (Fig. 3). The neoplasm
was negative for CD 138, CD 45, CD 99, HMB-45, desmin, myeloper-
oxidase, S-100, and vimentin.
3. Discussion
MCC  is a cutaneous neuroendocrine carcinoma, and an aggres-
sive neoplasm with a high propensity for metastasis. The tumor
mainly affects elderly Caucasians. The disease is rare with an annual
incidence ranging from 0.2 to 0.45 cases per 100,000 [18,19]. In a
review of 661 cases conducted in 2000, only 2% presented with no
apparent primary lesion [20].
Merkel cells reside in the basal layer and hair follicles of the
skin’s epidermis and are associated with mechanoreceptors in
the dermal papillae. It has been proposed that neuroendocrine
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2Fig. 3. The neoplasm shows paranuclear CK20 staining.
arcinoma of the skin arises from these cells. However, since MCC
s mainly a dermal tumor, an alternative hypothesis that they
riginate from immature pluripotential stem cells and acquire neu-
oendocrine characteristics upon malignant transformation [21]
s perhaps more plausible. The occasional presence of squamous
r eccrine differentiation in these tumors also suggests stem cell
rigin [22].
It is estimated that 97.6% of MCC  cases occur in the skin and 0.4%
ccur in other locations [23]. MCC  has been reported in the lips and
ral cavity [24], parotid gland [25], and lymph nodes [26–29]. Only
% of all cases present without a primary site [20].
We think that our case and the two reported cases in the
etroperitoneal space represent a lymph node primary MCC. There
re several possible theories for the origin of the MCC. The ﬁrst is
hat the retroperitoneal mass could be a massively enlarged lymph
ode where nodal Merkel cells became neoplastic. Alternatively,
n initial skin lesion could have spontaneously regressed, and the
etroperitoneal mass represents a single site of metastasis. Since
erkel cell precursors have never been identiﬁed within lymph
odes the latter theory seems more convincing, and is supported
y the fact that metastasis to the retroperitoneal lymph nodes has
een reported as relatively common when compared to other sites
uch as liver, bone, brain, and skin [30]. A third explanation is
hat the tumor might have arisen in subcutaneous soft tissues and
etastasized to the draining lymph nodes [31]. Finally, another the-
ry that could explain the lymph node as the primary site is that it
rose from primitive neuroectodermal (pluripotential) rests in the
ymph node [3].
Pathologically, is difﬁcult to accurately diagnose neuroen-
ocrine carcinoma due to its similarity to other poorly differen-
iated “small blue cell tumors” like small cell carcinoma of the
ung. Immunohistochemistry and molecular techniques are nec-
ssary for a deﬁnitive diagnosis. When found, perinuclear keratin
laments on an electron microscope and a dot-like pattern with CK
0 and CK 7 staining aid in diagnosis [32,33].
Regarding prognosis, MCC  of the skin is aggressive and has a high
ate of metastasis and recurrence. Survival rates for patients where
he disease has progressed beyond the primary lesion are compa-
able to those of patients with malignant melanoma, where nodal
pread is the best predictor of distant metastasis or death [34]. Pri-
ary nodal neuroendocrine carcinoma follows a less aggressive
ourse than the metastatic form of nodal involvement [35]. Thus,
ollow-up of patients may  provide insight into whether the nodal
isease was primary or metastatic.
The aggressive nature of this disease necessitates frequent
ollow-up. The presence of risk factors including tumors larger than
 cm,  trunk location, male sex, age over 65, nodal or distant diseasePEN  ACCESS
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at presentation, and duration of disease before presentation should
determine the appropriate frequency [36]. During examination, the
clinician should focus on the lymphatic and integumentary sys-
tems. When symptoms lead to suspicion of recurrence, appropriate
imaging studies should be performed.
Preoperative chemotherapy and excision of the primary tumor
is the surgical treatment of choice for retroperitoneal MCC. We  pro-
pose that further studies are needed to elucidate the true efﬁcacy of
chemotherapy in conventional as well as unconventional patients
with MCC.
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